XML 94 R80.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Summarized Stock Option Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Outstanding, Number of shares, Beginning Balance   1,294,832 1,331,651 1,331,651  
Granted, Number of shares   137,620      
Exercised   (249,521) (17,335)    
Forfeitures, Number of shares   (188,332) (466,033)    
Outstanding, Number of shares, Ending Balance 994,599 994,599 1,558,283 1,294,832 1,331,651
Exercisable, Number of Shares 464,506 464,506      
Vested and expected to vest, Number of shares 994,599 994,599      
Outstanding, Weighted average exercise price, Beginning Balance   $ 3.93 $ 5.83 $ 5.83  
Granted, Weighted average exercise price   4.87      
Exercised, weighted average exercise price   3.05 3.07    
Forfeitures, Weighted average exercise price   4.14 7.12    
Outstanding, Weighted average exercise price, Ending Balance $ 4.25 4.25 $ 4.24 $ 3.93 $ 5.83
Exercisable, Weighted average exercise price 5.37 5.37      
Vested and expected to vest, Weighted average exercise price $ 4.25 $ 4.25      
Outstanding, Weighted average remaining contractual term (in years)   6 years 10 months 9 days 7 years 9 months 18 days 7 years 8 months 4 days 7 years 6 months 21 days
Granted, Weighted average remaining contractual term (in years)   10 years      
Exercisable, Weighted average remaining contractual term (in years) 5 years 8 months 23 days        
Vested and expected to vest, Weighted average remaining contractual term (in years)   6 years 10 months 9 days      
Vested and expecting to vest, Aggregate intrinsic value $ 1,884 $ 1,884      
Outstanding, Aggregate intrinsic value, Beginning Balance   1,624 $ 0 $ 0  
Granted, Aggregate intrinsic value 235 235      
Exercised, Aggregate intrinsic value   470 35,000    
Exercisable, Aggregate intrinsic value 220 220      
Outstanding, Aggregate intrinsic value, Ending Balance $ 1,884 $ 1,884 $ 2,860 $ 1,624 $ 0
Outstanding, Weighted average grant date fair value, Beginning Balance   $ 1.45 $ 2.01 $ 2.01  
Granted, Weighted average grant date fair value   1.71      
Forfeitures, Weighted average grant date fair value   1.50 2.26    
Outstanding, Weighted average grant date fair value, Ending Balance $ 1.64 $ 1.64 $ 1.59 $ 1.45 $ 2.01
August 2020 [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Granted, Number of shares     150,000    
Granted, Weighted average exercise price     $ 3.50    
Granted, Weighted average remaining contractual term (in years)     3 years    
Granted, Aggregate intrinsic value     $ 166    
Granted, Weighted average grant date fair value     $ 1.11    
November 2020 [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Granted, Number of shares     560,000    
Granted, Weighted average exercise price     $ 3.01    
Granted, Weighted average remaining contractual term (in years)     10 years    
Granted, Aggregate intrinsic value     $ 691    
Granted, Weighted average grant date fair value     $ 1.23